Risk assessment of hepatitis E transmission through tissue allografts

World J Gastrointest Pathophysiol. 2022 Mar 22;13(2):50-58. doi: 10.4291/wjgp.v13.i2.50.

Abstract

Hepatitis E virus (HEV) is a small non-enveloped single stranded RNA virus whose genotypes 3 and 4 have been associated with zoonotic transmission in industrialized countries. HEV infection is considered the main cause of acute hepatitis worldwide. In some cases, transfusion of blood components or organ transplantation have been reported as the source of infection. We have conducted a literature review on the risk of transmission through cell and tissue allografts. Although no case was found, measures to control this risk should be taken when donor profile (based upon geographical and behavioural data) recommended it. Issues to be considered in donor screening and tissue processing to assess and to reduce the risk of HEV transmission are approached.

Keywords: Bioburden reduction; Disease transmission; Donor screening; Hepatitis E; Risk assessment; Tissue allograft.

Publication types

  • Review